Verbatim response from Claude
Zepbound vs. Compounded Tirzepatide: Is the Brand Worth It?
The Honest Answer: It Depends on Your Situation
Arguments FOR Zepbound (Brand)
- FDA-verified quality – Eli Lilly's manufacturing meets strict standards for purity and potency
- Consistent dosing – Each pen delivers exactly what's labeled
- Covered by some insurance – Can bring cost to $25-$550/month depending on plan
- Lilly's savings card – Brings it to ~$550/month without insurance (or $25 with qualifying coverage)
- No shortage concerns – Stable, reliable supply
Arguments FOR Compounded Tirzepatide
- Significantly cheaper – Often $150-$400/month from reputable compounders
- Flexible dosing – Can customize doses more easily
- Accessible without insurance battles
Key Risks with Compounded
- Quality varies enormously by pharmacy
- FDA has flagged some compounders for safety issues
- Tirzepatide is now off the shortage list, meaning most compounding is technically no longer legal
My Recommendation
Go with Zepbound if you can, especially using Lilly's savings program. The regulatory situation around compounded tirzepatide is increasingly risky legally and medically.
If cost is the barrier, explore Lilly's income-based assistance programs before defaulting to compounders.